Target intelligence / Profile preview

Imidazoline2 Binding Site (I2BS)

Target
I2BS
Molecular classification
Binding Site
01

Overview

The imidazoline2 binding site (I2BS), also known as the imidazoline I₂ receptor, refers to a group of non-adrenergic binding sites in the brain and peripheral tissues that are distinct from classical adrenergic receptors. These sites were originally identified due to their high affinity for certain radiolabeled ligands such as [³H]-idazoxan and [³H]-2-BFI. The molecular identity of I2BS remains elusive; evidence suggests that multiple proteins may constitute these binding sites. I2BS are predominantly expressed in reactive astrocytes and are implicated in various neurological disorders.

Other names
Imidazoline I₂ receptor
02

Mechanism of action

Unclear; ligands bind to I2BS, influencing glial cell activity and potentially affecting various neurological processes.

03

Biological functions

Regulation of GFAP expressionPain modulationInflammation controlNeurodegeneration processesTumor biology
04

Disease associations

Alzheimer's diseaseParkinson's diseaseDepressionAddictionGliomaHuntington’s choreaNeuroinflammation
05

Safety considerations

Lack of specific I2BS inhibitorsComplexity of I2BS molecular identity
06

Interacting drugs

Idazoxan

4 more in the full profile.

07

Biomarkers

I2BS density in neurodegenerative conditions

Beyond the preview

Go deeper on Imidazoline2 Binding Site (I2BS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Imidazoline2 Binding Site (I2BS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call